Core Cap Advisors, LLC Theravance Biopharma, Inc. Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 27 shares of TBPH stock, worth $247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27Holding current value
$247% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TBPH
# of Institutions
136Shares Held
47.3MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$87.1 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$68.3 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$43.6 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$34.6 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$25.3 Million3.74% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $612M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...